Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated:  8/5/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated: 8/5/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated:  8/5/2015
Clinical Research Facility
mi
from
Detroit, MI
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated: 8/5/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated:  8/5/2015
Clinical Research Facility
mi
from
New Hyde Park, NY
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated: 8/5/2015
Clinical Research Facility
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated:  8/5/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated: 8/5/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated:  8/5/2015
Clinical Research Facility
mi
from
Durham, NC
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated: 8/5/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated:  8/5/2015
Clinical Research Facility
mi
from
Cleveland, OH
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated: 8/5/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated:  8/5/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated: 8/5/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated:  8/5/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated: 8/5/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated:  8/5/2015
mi
from
Brisbane,
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Status: Enrolling
Updated: 8/5/2015
mi
from
Brisbane,
Click here to add this to my saved trials
Virtual LV Lead Navigation in Patients With Ischemic Cardiomyopathy
Virtual Left Ventricular Lead Navigation in Patients With Ischemic Cardiomyopathy
Status: Enrolling
Updated:  8/5/2015
UPMC Presbyterian Hospital
mi
from
Pittsburgh, PA
Virtual LV Lead Navigation in Patients With Ischemic Cardiomyopathy
Virtual Left Ventricular Lead Navigation in Patients With Ischemic Cardiomyopathy
Status: Enrolling
Updated: 8/5/2015
UPMC Presbyterian Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Optical Coherence Tomography Imaging of Post Coil Aneurysm Healing.
Optical Coherence Tomography Imaging of Post Coil Aneurysm Healing.
Status: Enrolling
Updated:  8/5/2015
Beckman Laser Institute University of California Irvine
mi
from
Irvine, CA
Optical Coherence Tomography Imaging of Post Coil Aneurysm Healing.
Optical Coherence Tomography Imaging of Post Coil Aneurysm Healing.
Status: Enrolling
Updated: 8/5/2015
Beckman Laser Institute University of California Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Optical Coherence Tomography Imaging of Post Coil Aneurysm Healing.
Optical Coherence Tomography Imaging of Post Coil Aneurysm Healing.
Status: Enrolling
Updated:  8/5/2015
Neurosurgery department, University of California,Irvine
mi
from
Irvine, CA
Optical Coherence Tomography Imaging of Post Coil Aneurysm Healing.
Optical Coherence Tomography Imaging of Post Coil Aneurysm Healing.
Status: Enrolling
Updated: 8/5/2015
Neurosurgery department, University of California,Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Complete Occlusion of Coilable Aneurysms
Complete Occlusion of Coilable Aneurysms
Status: Enrolling
Updated:  8/5/2015
Barrow Neurological Institute
mi
from
Phoenix, AZ
Complete Occlusion of Coilable Aneurysms
Complete Occlusion of Coilable Aneurysms
Status: Enrolling
Updated: 8/5/2015
Barrow Neurological Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Complete Occlusion of Coilable Aneurysms
Complete Occlusion of Coilable Aneurysms
Status: Enrolling
Updated:  8/5/2015
SUNY Stony Brook
mi
from
Stony Brook, NY
Complete Occlusion of Coilable Aneurysms
Complete Occlusion of Coilable Aneurysms
Status: Enrolling
Updated: 8/5/2015
SUNY Stony Brook
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Randomized Crossover of NAVA and Synchronized Intermittent Pressure Ventilation in Neonates and Infants
Respiratory Severity and Caloric Consumption on NAVA: Randomized Crossover Trial of NAVA and SIMV
Status: Enrolling
Updated:  8/5/2015
Children's Mercy Hospital
mi
from
Kansas City, MO
Randomized Crossover of NAVA and Synchronized Intermittent Pressure Ventilation in Neonates and Infants
Respiratory Severity and Caloric Consumption on NAVA: Randomized Crossover Trial of NAVA and SIMV
Status: Enrolling
Updated: 8/5/2015
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery
PROSPECTIVE STUDY ON PREOPERATIVE VERSUS POSTOPERATIVE VENOUS THROMBOPROPHYLAXIS IN PATIENTS UNDERGOING MAJOR COLORECTAL SURGERY
Status: Enrolling
Updated:  8/6/2015
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery
PROSPECTIVE STUDY ON PREOPERATIVE VERSUS POSTOPERATIVE VENOUS THROMBOPROPHYLAXIS IN PATIENTS UNDERGOING MAJOR COLORECTAL SURGERY
Status: Enrolling
Updated: 8/6/2015
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection
Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection.
Status: Enrolling
Updated:  8/7/2015
University of Colorado Hospital
mi
from
Aurora, CO
Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection
Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection.
Status: Enrolling
Updated: 8/7/2015
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
Assessment of the Safety, Side Effects and Efficacy of Interventional Cryotherapy for the Eradication of Benign Airway Disease("ICE THE BAD")
Status: Enrolling
Updated:  8/11/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
Assessment of the Safety, Side Effects and Efficacy of Interventional Cryotherapy for the Eradication of Benign Airway Disease("ICE THE BAD")
Status: Enrolling
Updated: 8/11/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Enhancing Caregiver Support for Heart Failure Patients: the CarePartner Study
Enhancing Caregiver Support for Patients With Heart Failure
Status: Enrolling
Updated:  8/12/2015
VA Ann Arbor Healthcare System
mi
from
Ann Arbor, MI
Enhancing Caregiver Support for Heart Failure Patients: the CarePartner Study
Enhancing Caregiver Support for Patients With Heart Failure
Status: Enrolling
Updated: 8/12/2015
VA Ann Arbor Healthcare System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Enhancing Caregiver Support for Heart Failure Patients: the CarePartner Study
Enhancing Caregiver Support for Patients With Heart Failure
Status: Enrolling
Updated:  8/12/2015
VA Medical Center, Cleveland
mi
from
Cleveland, OH
Enhancing Caregiver Support for Heart Failure Patients: the CarePartner Study
Enhancing Caregiver Support for Patients With Heart Failure
Status: Enrolling
Updated: 8/12/2015
VA Medical Center, Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated:  8/12/2015
Novartis Investigative Site
mi
from
Little Rock, AR
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated: 8/12/2015
Novartis Investigative Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated:  8/12/2015
Novartis Investigator Site
mi
from
Chicago, IL
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated: 8/12/2015
Novartis Investigator Site
mi
from
Chicago, IL
Click here to add this to my saved trials
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated:  8/12/2015
Novartis Investigative Site
mi
from
Detroit, MI
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated: 8/12/2015
Novartis Investigative Site
mi
from
Detroit, MI
Click here to add this to my saved trials
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated:  8/12/2015
Novartis Investigative Site
mi
from
Grand Island, NE
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated: 8/12/2015
Novartis Investigative Site
mi
from
Grand Island, NE
Click here to add this to my saved trials
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated:  8/12/2015
Novartis Investigative Site
mi
from
Lincoln, NE
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated: 8/12/2015
Novartis Investigative Site
mi
from
Lincoln, NE
Click here to add this to my saved trials
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated:  8/12/2015
Novartis Investigative Site
mi
from
Oklahoma City, OK
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated: 8/12/2015
Novartis Investigative Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated:  8/12/2015
Novartis Investigative Site
mi
from
Tulsa, OK
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated: 8/12/2015
Novartis Investigative Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated:  8/12/2015
Novartis Investigative Site
mi
from
Hillsboro, OR
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated: 8/12/2015
Novartis Investigative Site
mi
from
Hillsboro, OR
Click here to add this to my saved trials
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated:  8/12/2015
Novartis Investigative Site
mi
from
Wyomissing, PA
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated: 8/12/2015
Novartis Investigative Site
mi
from
Wyomissing, PA
Click here to add this to my saved trials
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated:  8/12/2015
Novartis Investigative Site
mi
from
Nashville, TN
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated: 8/12/2015
Novartis Investigative Site
mi
from
Nashville, TN
Click here to add this to my saved trials
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated:  8/12/2015
Novartis Investigative Site
mi
from
Houston, TX
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated: 8/12/2015
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated:  8/12/2015
Novartis Investigative Site
mi
from
Caba,
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Status: Enrolling
Updated: 8/12/2015
Novartis Investigative Site
mi
from
Caba,
Click here to add this to my saved trials
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
Status: Enrolling
Updated:  8/12/2015
University of North Carolina Hospitals and Clinics
mi
from
Chapel Hill, NC
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
Status: Enrolling
Updated: 8/12/2015
University of North Carolina Hospitals and Clinics
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Changes in Doppler Signals From the Lung Due to Cardiac Resynchronization in Heart Failure Patients
Lung Doppler Signals Changes in Response to Cardiac Resynchronization in Heart Failure Patients
Status: Enrolling
Updated:  8/12/2015
The Ohio State University 473 West 12th Ave.
mi
from
Columbus, OH
Changes in Doppler Signals From the Lung Due to Cardiac Resynchronization in Heart Failure Patients
Lung Doppler Signals Changes in Response to Cardiac Resynchronization in Heart Failure Patients
Status: Enrolling
Updated: 8/12/2015
The Ohio State University 473 West 12th Ave.
mi
from
Columbus, OH
Click here to add this to my saved trials
Assessment of Coronary Plaque Composition Using Optical Coherence Tomography
Assessment of Coronary Plaque Composition Using Optical Coherence Tomography During Chronic Inhibition of Lp-PLa2 Activity
Status: Enrolling
Updated:  8/13/2015
The Mayo Clinic
mi
from
Rochester, MN
Assessment of Coronary Plaque Composition Using Optical Coherence Tomography
Assessment of Coronary Plaque Composition Using Optical Coherence Tomography During Chronic Inhibition of Lp-PLa2 Activity
Status: Enrolling
Updated: 8/13/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
A Lifestyle Physical Activity Intervention for Older Sedentary Women
A Lifestyle Physical Activity Intervention for Older Sedentary Women
Status: Enrolling
Updated:  8/13/2015
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
A Lifestyle Physical Activity Intervention for Older Sedentary Women
A Lifestyle Physical Activity Intervention for Older Sedentary Women
Status: Enrolling
Updated: 8/13/2015
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Arterial Stiffness in Type I Diabetes Mellitus
Acute Effect of a Mixed Meal With and Without Extra Insulin on Arterial Stiffness, a Prospective Randomized Study.
Status: Enrolling
Updated:  8/13/2015
University of Florida
mi
from
Gainesville, FL
Arterial Stiffness in Type I Diabetes Mellitus
Acute Effect of a Mixed Meal With and Without Extra Insulin on Arterial Stiffness, a Prospective Randomized Study.
Status: Enrolling
Updated: 8/13/2015
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Angel® Catheter Early Feasibility Clinical Study
A Multi-center, Early Feasibility Study of the Angel® Catheter in Critically Ill Subjects at High Risk of Pulmonary Embolism
Status: Enrolling
Updated:  8/14/2015
University of Mississippi Medical Center
mi
from
Jackson, MS
Angel® Catheter Early Feasibility Clinical Study
A Multi-center, Early Feasibility Study of the Angel® Catheter in Critically Ill Subjects at High Risk of Pulmonary Embolism
Status: Enrolling
Updated: 8/14/2015
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Angel® Catheter Early Feasibility Clinical Study
A Multi-center, Early Feasibility Study of the Angel® Catheter in Critically Ill Subjects at High Risk of Pulmonary Embolism
Status: Enrolling
Updated:  8/14/2015
Oregon Health and Science University
mi
from
Portland, OR
Angel® Catheter Early Feasibility Clinical Study
A Multi-center, Early Feasibility Study of the Angel® Catheter in Critically Ill Subjects at High Risk of Pulmonary Embolism
Status: Enrolling
Updated: 8/14/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Angel® Catheter Early Feasibility Clinical Study
A Multi-center, Early Feasibility Study of the Angel® Catheter in Critically Ill Subjects at High Risk of Pulmonary Embolism
Status: Enrolling
Updated:  8/14/2015
UT Southwestern Medical Center
mi
from
Dallas, TX
Angel® Catheter Early Feasibility Clinical Study
A Multi-center, Early Feasibility Study of the Angel® Catheter in Critically Ill Subjects at High Risk of Pulmonary Embolism
Status: Enrolling
Updated: 8/14/2015
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Angel® Catheter Early Feasibility Clinical Study
A Multi-center, Early Feasibility Study of the Angel® Catheter in Critically Ill Subjects at High Risk of Pulmonary Embolism
Status: Enrolling
Updated:  8/14/2015
The University of Texas, Houston
mi
from
Houston, TX
Angel® Catheter Early Feasibility Clinical Study
A Multi-center, Early Feasibility Study of the Angel® Catheter in Critically Ill Subjects at High Risk of Pulmonary Embolism
Status: Enrolling
Updated: 8/14/2015
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function
Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function
Status: Enrolling
Updated:  8/15/2015
VA Medical Center
mi
from
Birmingham, AL
Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function
Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function
Status: Enrolling
Updated: 8/15/2015
VA Medical Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function
Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function
Status: Enrolling
Updated:  8/15/2015
UAB Hospital
mi
from
Birmingham, AL
Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function
Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function
Status: Enrolling
Updated: 8/15/2015
UAB Hospital
mi
from
Birmingham, AL
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
Indianapolis Neurosurgical Group
mi
from
Indianapolis, IN
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
Indianapolis Neurosurgical Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
Massachusetts General Hospital
mi
from
Boston, MA
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
Washington University
mi
from
St. Louis, MO
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
University of Virginia
mi
from
Charlottesville, VA
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
University of Alabama
mi
from
Birmingham, AL
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
University of California
mi
from
San Francisco, CA
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
University of California
mi
from
San Francisco, CA
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
University of Florida
mi
from
Gainesville, FL
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials